Miami Debates in Hematologic Malignancies (MDHM 2022) is a conference dedicated to up-to-date review of the latest news in the field of hematologic malignancies.
Miami Debates in Hematologic Malignancies (MDHM 2022) covers topics such as:
- Bispecific and conjugated monoclonal antibodies
- Optimal treatments for newly diagnosed and relapsed patients
- Minimal residual disease (MRD) testing in the clinic
- Chemotherapy-free treatments
- Future role of bone marrow transplant
- CAR T cell and CAR NK cell therapies
- New drugs in development
Miami Debates in Hematologic Malignancies (MDHM 2022) brings together:
- Healthcare clinicians
- Hematologists
- Medical
- Hematologic oncologists
- Physicians
- Radiation and surgical oncologists
- Nurse practitioners
- Oncology nurses
- Researchers
- Occupational therapists
- Pharmacists and industry professionals working in the fields of oncology and hematology.
